Transfecting this siRNA into SSc fibroblasts efficiently suppressed PDGFR-α mRNA and protein expression, thus blocking PDGF-AA binding to PDGFR-α on the surface of activated fibroblasts. The gene discussed is PDGFRA; the disease is systemic sclerosis.